Anti-GD2 monoclonal antibody
Showing 9976 - 10000 of >10,000
Advanced or Metastatic Biliary Tract Cancer Trial in China (MRG002)
Recruiting
- Advanced or Metastatic Biliary Tract Cancer
-
Bengbu, Anhui, China
- +6 more
Dec 8, 2021
Covid19 Trial in Botucatu (Heparin sodium, Placebo)
Recruiting
- Covid19
- Heparin sodium
- Placebo
-
Botucatu, Sao Paulo, Brazil
- +1 more
Sep 27, 2021
Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma Trial in Worldwide (derazantinib)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Combined Hepatocellular and Cholangiocarcinoma
-
Phoenix, Arizona
- +40 more
Mar 7, 2022
Covid-19 Trial in Grenoble (Mixture 3,6% H2 in N2 (96.4%))
Recruiting
- Covid-19
- Mixture 3,6% H2 in N2 (96.4%)
-
Grenoble, FranceCHU de Grenoble Alpes
May 24, 2022
Plantar Fascitis Trial in Ankara (Ozone Generator, Extracorporeal shock wave therapy device)
Recruiting
- Plantar Fascitis
- Ozone Generator
- Extracorporeal shock wave therapy device
-
Ankara, TurkeyAnkara Bilkent City Hospital
Sep 11, 2023
CD19-positive, Acute Lymphoblastic Leukemia Trial in Shanghai (Human CD19 targeted T Cells Injection)
Recruiting
- CD19-positive
- Acute Lymphoblastic Leukemia
- Human CD19 targeted T Cells Injection
-
Shanghai, Shanghai, ChinaShanghai General Hospital
Aug 29, 2021
Immune System Tolerance, Depression, Obesity Trial in Graz (Aronia Juice, Placebo)
Recruiting
- Immune System Tolerance
- +4 more
- Aronia Juice
- Placebo
-
Graz, Styria, AustriaMedical Universtiy of Graz
Jun 20, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +110 more
- rituximab
- +12 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 6, 2019
Juvenile Psoriatic Arthritis, Enthesitis-related Arthritis Trial in Worldwide (secukinumab, )
Completed
- Juvenile Psoriatic Arthritis
- Enthesitis-related Arthritis
- secukinumab
- placebo
-
Los Angeles, California
- +30 more
Aug 12, 2022
Relapsed/Refractory Multiple Myeloma(MM) Trial in Guangdong (CART therapy in Relapsed/Refractory multiple myeloma)
Terminated
- Relapsed/Refractory Multiple Myeloma(MM)
- CART therapy in Relapsed/Refractory multiple myeloma
-
Guangdong, Guangdong, ChinaSouthern Medical University Zhujiang Hospital
Sep 17, 2021
Merkel Cell Carcinoma Trial in Stanford (Pembrolizumab, Radiation Therapy)
Terminated
- Merkel Cell Carcinoma
- Pembrolizumab
- Radiation Therapy
-
Stanford, CaliforniaStanford University
Aug 5, 2021
Immune Profiles in Myasthenia Gravis
Not yet recruiting
- Myasthenia Gravis
- (no location specified)
Oct 13, 2021
Juvenile Idiopathic Arthritis Trial in Uppsala (Specific carbohydrate diet)
Recruiting
- Juvenile Idiopathic Arthritis
- Specific carbohydrate diet
-
Uppsala, SwedenUnit of Pediatric Rheumatology, Akademiska hospital
Mar 24, 2021
Extensive Stage Lung Small Cell Carcinoma Trial in Duarte (Atezolizumab, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Atezolizumab
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022
Sepsis, Sepsis Mrsa, Sepsis Bacteremia Trial in United States (Multifaceted de-implementation strategy to reduce vancomycin
Not yet recruiting
- Sepsis
- +6 more
- Multifaceted de-implementation strategy to reduce vancomycin overuse
-
Atlanta, Georgia
- +3 more
Jul 27, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston
Completed
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Bintrafusp Alfa
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Mar 3, 2022
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Topotecan)
Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer Trial in Spain (Ipilimumab, Nivolumab, Carboplatin)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Ipilimumab
- +5 more
-
Badalona, Barcelona, Spain
- +17 more
Jun 1, 2022
Lymphoma, Extranodal NK-T-Cell Trial in Shanghai (Pembrolizumab, Involved Field Radiation Therapy)
Recruiting
- Lymphoma, Extranodal NK-T-Cell
- Pembrolizumab
- Involved Field Radiation Therapy
-
Shanghai, ChinaShanghai Rui-Jin Hospital
Mar 29, 2022